Global Network for Women's and Children's Health Research Data Coordinating Center
- Institution
- RESEARCH TRIANGLE INSTITUTE, NC
- Principal investigator
- Elizabeth M Mcclure
- Funding
- $1.7M
- Duration
- 2017–2030
Moonbase score
Still being scored
Abstract
Project Summary/Abstract To improve women’s and children’s health and make progress in addressing the U.N.’s Sustainable Development Goals (SDGs), there is a need to continue researching sustainable, cost-effective health interventions and strengthening research infrastructure and public health intervention capabilities in developing countries. The NICHD Global Network (GN) is critical to helping the U.S. government address the SDGs to reduce maternal mortality and end preventable newborn and child mortality. There is a crucial need for an independent Data Coordinating Center (DCC) to provide statistical and operational expertise that helps the GN complete high-impact research to influence policy. RTI has been the GN’s DCC since 2001 and proposes to continue in this role for the next cycle. We will maximize the global impact of the GN and ensure a productive and accessible GN by collaborating with study investigators—both within and outside the Network—to develop rigorous and relevant Network research protocols and budgets. We will ensure seamless incorporation of research protocols developed by both GN and non-Network investigators through systems developed to inform study design using knowledge of the GN sites. (1) Optimize the scientific quality and operational efficiency of GN studies by supporting protocol design, training, implementation, and study monitoring; developing rigorous statistical analysis plans; incorporating common data elements; and effectively procuring external services, as needed, to support the research implementation. (2) Ensure high- quality data collection and data management, rigorous monitoring of study progress, quality, and participant safety. (3) Maximize the validity and scientific impact of Network research by providing timely, accurate statistical analyses of GN research to support publication of study results; ensuring timely dissemination and public sharing of data at study completion; and supporting study oversight by the Data Safety Monitoring Board, the Steering Committee, research units, NICHD. (4) Enhance the efficiency, productivity, and outreach of Network operations to Network and non-Network investigators by providing broad logistical support, including telecommunications, meeting coordination and organization, web-based internal and external communication systems, and regulatory support. Dr. Elizabeth McClure, the proposed PI, has extensive experience in maternal and newborn studies, and will be assisted by senior research staff with significant GN experience. This application has unique strengths to help advance the GN research agenda: (1) a highly qualified, collaborative PI and staff with in-depth knowledge; (2) proven track record of scientific productivity and leveraging the GN infrastructure to address emerging issues to advance NICHD scientific goals; (3) robust data systems customized for the GN to ensure data quality for harmonized research; (4) experts in biostatistics, epidemiology, community health, nutrition, infant development, and health economics; and (5) a flexible administrative structure to help realize the NICHD vision to optimize the GN.
LOADING MOONBASE SCORE
Questions for RESEARCH TRIANGLE INSTITUTE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Research Triangle InstituteNot yet scored
Stillbirth Research Consortium Data Coordinating Center
Carla M Bann · $2.1M · 2025–2030
- NIH · Research Triangle InstituteNot yet scored
A Prospective Randomized Controlled Trial to Evaluate the Impact of Treatment of Asymptomatic Bacteriuria on Low Birth Weight
Christian A Chisholm · $1.1M · 2024–2028
- NIH · Research Triangle Institute44
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences
Rangan Maitra · $562K · 2016–2028